4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18010399 | INJECTABLE COMPOSITION COMPRISING GnRH ANALOGUE | VARADARAJ, ARCHANA | 1658 | Non-Final OA | Dec 14, 2022 |
| 17995947 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | REILLY, SOPHIA JANE | 1627 | Non-Final OA | Oct 11, 2022 |
| 17801057 | PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE AND SODIUM BICARBONATE HAVING EXCELLENT RELEASE PROPERTIES | WESTERBERG, NISSA M | 1618 | Final Rejection | Aug 19, 2022 |
| 17614967 | 1, 3, 4-Oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | LEE, CHIHYI NMN | 1628 | Final Rejection | Nov 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial